Screener
Cogent Biosciences, Inc. COGT Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Cogent Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: Cogent Biosciences, Inc.’s 10-Q, filed August 10, 2026.
- Filed
- Aug 10, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-342393
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Operating lease, right-of-use assets | 22,596 | 18,078 |
| Property and equipment, net | 4,775 | 5,457 |
| Restricted cash | 416 | 416 |
| Other assets | 1,939 | 3,301 |
| Total assets | $834,546 | $937,607 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $7,488 | $9,504 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Cogent Biosciences, Inc.'s deferred tax assets and other non-current assets?
- Cogent Biosciences, Inc. (COGT) reported deferred tax assets and other non-current assets of $1.94M in Q2 2026.
- How has Cogent Biosciences, Inc.'s deferred tax assets and other non-current assets changed year-over-year?
- Cogent Biosciences, Inc.'s deferred tax assets and other non-current assets decreased by 60.1% year-over-year, from $4.86M to $1.94M.
- What is the long-term trend for Cogent Biosciences, Inc.'s deferred tax assets and other non-current assets?
- Over 4 years (2021 to 2025), Cogent Biosciences, Inc.'s deferred tax assets and other non-current assets has grown at a -3.0% compound annual growth rate (CAGR), from $3.73M to $3.3M.
- What does deferred tax assets and other non-current assets mean?
- Combined balance of non-current deferred tax assets and other miscellaneous non-current assets.
Ask your AI about Cogent Biosciences, Inc.'s deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude